表紙
市場調查報告書

歐洲的泌尿系統用醫療設備市場分析 (2019∼2025年)

Urological Devices Market Report Suite | Europe | 2019-2025| MedSuite

出版商 iData Research Inc. 商品編碼 918703
出版日期 內容資訊 英文 640 Pages
商品交期: 最快1-2個工作天內
價格
歐洲的泌尿系統用醫療設備市場分析 (2019∼2025年) Urological Devices Market Report Suite | Europe | 2019-2025| MedSuite
出版日期: 2019年02月03日內容資訊: 英文 640 Pages
簡介

本報告提供歐洲各國的泌尿科醫療設備的市場相關分析,市場背景情況和基本結構,整體市場趨勢預測 (銷售量、收益額、平均價格,市場成長率等,過去4年、今後7年份),各分類的詳細趨勢,主要的推動及阻礙市場要素,近來的市場形勢 (資本交易等),主要企業的簡介等資訊彙整,為您概述為以下內容。

摘要整理

歐洲的泌尿系統用醫療設備的市場:概要

競爭分析

市場趨勢

市場發展

治療數量

分析對象市場

主要報告的更新情形

過去的版本

分析方法

  • 分析範圍
  • iData的9等級分析方法

疾病概要

  • 人體的基本結構
    • 泌尿器官系統 (男性/女性)
  • 疾病的治療、診斷方法
    • 前列腺肥大症 (BPH)
    • 尿失禁
    • 泌尿道感染 (UTI)
    • 腎臟結石
    • 膀胱脫
    • 膀胱過動症
    • 前列腺炎
    • 勃起功能障礙 (ED)
    • 癌症 (前列腺癌症,膀胱癌)
  • 患者數的規模、結構

產品評估

  • 簡介
  • 產品系列
  • 法規上的課題和回收
  • 臨床實驗趨勢

歐洲的泌尿系統用醫療設備市場概要

  • 匯率
  • 市場概要
  • 各部門趨勢分析
  • 推動及阻礙市場要素
  • 各企業市場佔有率分析
  • 企業合併、收購 (M&A)
  • 企業簡介
    • Boston Scientific
    • C. R. Bard (Becton Dickinson)
    • Coloplast
    • Cook Medical
    • Elekta
    • Ethicon
    • Karl Storz
    • Laborie
    • Medline
    • Olympus
  • SWOT分析

各國的簡介

  • 簡介
    • 總人口
    • 每人GDP
    • 價格指數
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

治療數量

  • 治療概要

前列腺肥大症 (BPH) 治療設備的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • TURP (經尿道前列腺切除術) 市場
      • 單極電極
      • 雙極電極
    • 雷射式BPH治療市場
      • BPH用雷射設備
      • BPH雷射治療用光纖
    • UroLift市場
    • Rezum市場
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

近接治療設備市場

  • 簡介
  • 市場分析與預測
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

尿道導管市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 尿道導管市場全體
    • 間歇式導管
    • 導尿管 (留置型導管)
    • 保險套導管 (男性用外置導管)
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

腎瘺造設用設備的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 球囊擴張設備
    • 排液管
    • 經皮型腎瘺 (PCN) 接取
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析
    • 尿道導管
      • 間歇式導管
        • 塗料型
        • 非塗料型
        • 封閉系統型
      • 留置型導管 (導尿管)
        • 塗料型
        • 非塗料型
        • 封閉系統型
      • 男性用外置導管
      • 男性用/女性用
    • 失禁管理設備
      • 女性用失禁吊帶
      • 男性用置入式設備
        • 置入式吊帶
        • 人工尿道括約肌
    • 收尿袋
      • 床邊用袋子
      • 腿袋

尿失禁用設備的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 尿道膨脹劑
    • 尿失禁吊帶市場全體
      • 女性用尿失禁吊帶
        • TVT (經陰道膠帶式) 吊帶
        • TOT (經封閉孔、膠帶式) 吊帶
        • 單一解剖吊帶
      • 男性用尿失禁吊帶
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

結石管理設備的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 體外震波碎石術 (ESWL) 設備市場
    • 鈥雷射市場
    • 結石打碎、消除設備市場
      • 腈製設備 (桶子,把持器)
      • 不鏽鋼製設備 (桶子,把持器)
    • 尿道支架市場市場
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

泌尿系統內視鏡的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 泌尿系統內視鏡市場全體
    • 膀胱鏡子
      • 剛性膀胱鏡子
      • 軟性膀胱鏡子
    • 輸尿管鏡
    • 切除用內視鏡
    • 腎盂輸尿管鏡
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

勃起功能障礙 (ED) 治療設備的市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • ED治療設備市場全體
    • 膨脹式ED治療設備
    • 延伸式 (植入) ED治療設備
  • 推動及阻礙市場要素
  • 各企業的市場佔有率分析

簡稱一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_EUUR19_MS

The full report suite on the European market for urological devices includes devices for benign prostate hyperplasia (BPH), brachytherapy, urinary catheters, nephrostomy, urinary incontinence, stone management, urological endoscopes and erectile dysfunction (ED).

Overall, the urological device market is very well established. This limits the potential for substantial growth. Although companies continue to provide novel adaptations for their products, the general trend within the market is a relatively flat ASP. Additionally, the ASP has been limited by the lack of reimbursement in some countries and price pressures witnessed across Europe.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES XIII

LIST OF CHARTS XXV

EXECUTIVE SUMMARY 1

EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 6

MARKET DEVELOPMENTS 8

PROCEDURE NUMBERS 9

MARKETS INCLUDED 10

KEY REPORT UPDATES 12

VERSION HISTORY 12

RESEARCH METHODOLOGY 13

  • Step 1: Project Initiation & Team Selection 13
  • Step 2: Prepare Data Systems and Perform Secondary Research 16
  • Step 3: Preparation for Interviews & Questionnaire Design 18
  • Step 4: Performing Primary Research 19
  • Step 5: Research Analysis: Establishing Baseline Estimates 21
  • Step 6: Market Forecast and Analysis 22
  • Step 7: Identify Strategic Opportunities 24
  • Step 8: Final Review and Market Release 25
  • Step 9: Customer Feedback and Market Monitoring 26

DISEASE OVERVIEW 27

  • 2.1 BASIC ANATOMY 27
    • 2.1.1 Urinary System 27
      • 2.1.1.1 Male Urinary System 28
      • 2.1.1.2 Female Urinary System 29
  • 2.2 DISEASE TREATMENT AND DIAGNOSTICS 30
    • 2.2.1 Benign Prostatic Hyperplasia 30
    • 2.2.2 Urinary Incontinence 31
    • 2.2.3 Urinary Tract Infections 33
    • 2.2.4 Kidney Stones 34
    • 2.2.5 Bladder Prolapse 36
    • 2.2.6 Overactive Bladder 37
    • 2.2.7 Prostatitis 38
    • 2.2.8 Erectile Dysfunction 40
    • 2.2.9 Cancer 41
      • 2.2.9.1 Prostate Cancer 41
      • 2.2.9.2 Bladder Cancer 42
  • 2.3 PATIENT DEMOGRAPHICS 44
    • 2.3.1 Benign Prostatic Hyperplasia 44
    • 2.3.2 Urinary Incontinence 44
    • 2.3.3 Urinary Tract Infections 45
    • 2.3.4 Kidney Stones 46
    • 2.3.5 Bladder Prolapse 46
    • 2.3.6 Overactive Bladder 47
    • 2.3.7 Prostatitis 48
    • 2.3.8 Erectile Dysfunction 48
    • 2.3.9 Cancer 49
      • 2.3.9.1 Prostate Cancer 49
      • 2.3.9.2 Bladder Cancer 50

PRODUCT ASSESSMENT 51

  • 3.1 INTRODUCTION 51
  • 3.2 PRODUCT PORTFOLIOS 51
    • 3.2.1 Urinary Incontinence 51
      • 3.2.1.1 Urinary Catheters 51
      • 3.2.1.1.1 Intermittent Catheters 51
      • 3.2.1.1.2 Foley Catheters 52
      • 3.2.1.1.3 Male External Catheters 53
      • 3.2.1.2 Urethral Bulking Agents 54
      • 3.2.1.3 Incontinence Management Devices 55
      • 3.2.1.3.1 Female Incontinence Slings 55
      • 3.2.1.3.2 Male Implantable Devices 55
      • 3.2.1.4 Urine Bags 57
      • 3.2.1.4.1 Leg Bags 57
      • 3.2.1.4.2 Night Bags 58
    • 3.2.2 Stone Management 62
      • 3.2.2.1 ESWL Equipment 62
      • 3.2.2.2 ISWL Equipment 63
      • 3.2.2.3 Holmium Lasers 63
      • 3.2.2.4 Stone Fragment Retrieval Devices 64
      • 3.2.2.5 Ureteral Stents 64
    • 3.2.3 BPH Treatment 68
      • 3.2.3.1 TURP 68
      • 3.2.3.2 TUMT 69
      • 3.2.3.3 TUNA 69
      • 3.2.3.4 Prostatic Stents 70
      • 3.2.3.5 Laser BPH 71
      • 3.2.3.5.1 Photoselective Vaporization of the Prostate (PVP) 72
      • 3.2.3.5.2 Laser Vaporization of the Prostate 73
      • 3.2.3.5.3 Laser Ablation of the Prostate 73
      • 3.2.3.5.4 Laser Resection of the Prostate 74
      • 3.2.3.5.5 Laser Enucleation of the Prostate 75
    • 3.2.4 Urological Endoscopes 77
      • 3.2.4.1 Cystoscopes 77
      • 3.2.4.2 Ureteroscopes 78
      • 3.2.4.3 Resectoscopes 79
      • 3.2.4.4 Nephroscopes 79
    • 3.2.5 Prostate Cancer Treatment 83
      • 3.2.5.1 Brachytherapy 83
      • 3.2.5.1.1 Permanent Implants 83
      • 3.2.5.1.2 Temporary Implants 83
      • 3.2.5.2 Cryotherapy 85
    • 3.2.6 Urodynamics 87
      • 3.2.6.1 Urodynamic Equipment 87
      • 3.2.6.2 Urodynamic Consumables 88
      • 3.2.6.2.1 Water-charged Catheters 88
      • 3.2.6.2.2 Air-charged Catheters 89
      • 3.2.6.2.3 Fiber Optic Catheters 89
    • 3.2.7 Nephrostomy 91
      • 3.2.7.1 Percutaneous Nephrostomy Drainage Tubes & Sets 91
      • 3.2.7.2 Nephrostomy Balloon Catheters 92
      • 3.2.7.3 Ureteral Stents 92
    • 3.2.8 Erectile Dysfunction 96
      • 3.2.8.1 Penile Implants 96
      • 3.2.8.1.1 Inflatable 96
      • 3.2.8.1.2 Malleable 97
      • 3.2.8.2 Vacuum 97
  • 3.3 REGULATORY ISSUES AND RECALLS 99
    • 3.3.1 Boston Scientific 99
      • 3.3.1.1 Stone Management 99
      • 3.3.1.2 Nephrostomy 101
    • 3.3.2 C. R. Bard (Becton Dickinson) 102
      • 3.3.2.1 Urinary Incontinence 102
      • 3.3.2.2 Stone Management 107
      • 3.3.2.3 Urological Endoscopes 107
      • 3.3.2.4 Prostate Cancer Treatment 107
      • 3.3.2.5 Nephrostomy 108
    • 3.3.3 Coloplast 110
      • 3.3.3.1 Urinary Catheter 110
      • 3.3.3.2 Erectile Dysfunction 110
    • 3.3.4 Cook Medical 111
      • 3.3.4.1 Stone Management 111
      • 3.3.4.2 Nephrostomy 112
    • 3.3.5 Elekta 114
      • 3.3.5.1 Prostate Cancer Treatment 114
    • 3.3.6 Karl Storz 115
      • 3.3.6.1 Urological Endoscopes 115
    • 3.3.7 Olympus 116
      • 3.3.7.1 Urological Endoscopes 116
  • 3.4 CLINICAL TRIALS 118
    • 3.4.1 Boston Scientific 118
      • 3.4.1.1 Urinary Incontinence 118
      • 3.4.1.2 BPH Treatment 119
      • 3.4.1.3 Urological endoscopes 120
      • 3.4.1.4 Nephrostomy 121
      • 3.4.1.5 Erectile Dysfunction 122
    • 3.4.2 C. R. Bard (Becton Dickinson) 123
      • 3.4.2.1 Urinary Incontinence 123
      • 3.4.2.2 Prostate Cancer Treatment 125
    • 3.4.3 Coloplast 126
      • 3.4.3.1 Urinary Incontinence 126
    • 3.4.4 Cook Medical 129
      • 3.4.4.1 Nephrostomy 129
    • 3.4.5 Elekta 131
      • 3.4.5.1 Prostate Cancer Treatment 131
    • 3.4.6 Ethicon 133
      • 3.4.6.1 Urinary Incontinence 133
    • 3.4.7 Karl Storz 135
      • 3.4.7.1 Stone Management 135
      • 3.4.7.2 Urological Endoscopes 137
    • 3.4.8 Laborie 140
      • 3.4.8.1 Urodynamics 140
    • 3.4.9 Medline 142
      • 3.4.9.1 Urinary Incontinence 142
    • 3.4.10 Olympus 143
      • 3.4.10.1 Stone Management 143
      • 3.4.10.2 BPH Treatment 144
      • 3.4.10.3 Urological Endoscopes 145

EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW 147

  • 4.1 CURRENCY EXCHANGE RATE 147
  • 4.2 MARKET OVERVIEW 148
  • 4.3 TREND ANALYSIS BY SEGMENT 156
  • 4.4 DRIVERS AND LIMITERS 159
    • 4.4.1 Market Drivers 159
    • 4.4.2 Market Limiters 160
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS 162
  • 4.6 MERGERS AND ACQUISITIONS 169
  • 4.7 COMPANY PROFILES 170
    • 4.7.1 Boston Scientific 170
    • 4.7.2 C. R. Bard (Becton Dickinson) 172
    • 4.7.3 Coloplast 174
    • 4.7.4 Cook Medical 175
    • 4.7.5 Elekta 176
    • 4.7.6 Ethicon 177
    • 4.7.7 Karl Storz 178
    • 4.7.8 Laborie 179
    • 4.7.9 Medline 180
    • 4.7.10 Olympus 182
  • 4.8 SWOT ANALYSIS 184
    • 4.8.1 Boston Scientific 185
    • 4.8.2 C. R. Bard (Becton Dickinson) 187
    • 4.8.3 Coloplast 189
    • 4.8.4 Cook Medical 190
    • 4.8.5 Elekta 192
    • 4.8.6 Ethicon 193
    • 4.8.7 Karl Storz 194
    • 4.8.8 Laborie 195
    • 4.8.9 Medline 196
    • 4.8.10 Olympus 198

COUNTRY PROFILES 200

  • 5.1 INTRODUCTION 200
    • 5.1.1 Population 200
    • 5.1.2 GDP Per Capita 200
    • 5.1.3 Price Index 200
  • 5.2 GERMANY 201
  • 5.3 FRANCE 202
  • 5.4 UNITED KINGDOM 203
  • 5.5 ITALY 204
  • 5.6 SPAIN 205
  • 5.7 BENELUX 206
  • 5.8 SCANDINAVIA 207
  • 5.9 AUSTRIA 208
  • 5.10 SWITZERLAND 209
  • 5.11 PORTUGAL 210

PROCEDURE NUMBERS 211

  • 6.1 PROCEDURE OVERVIEW 211
  • 6.2 PROSTATE CANCER TREATMENT PROCEDURES 214
    • 6.2.1 Open and Laparoscopic Prostatectomy Procedures 219
    • 6.2.2 Robotic Prostatectomy Procedures 220
    • 6.2.3 Watchful Waiting Procedures 221
    • 6.2.4 HIFU Procedures 222
    • 6.2.5 Brachytherapy Procedures 223
    • 6.2.6 High Dose Radiation Procedures 224
    • 6.2.7 External Radiation Therapy (Primary) Procedures 225
    • 6.2.8 External Radiation Therapy (Secondary) Procedures 226
  • 6.3 INTERVENTIONAL BPH PROCEDURES 227
    • 6.3.1 TURP Procedures 231
    • 6.3.2 Laser BPH Procedures 232
  • 6.4 STONE MANAGEMENT PROCEDURES 233
    • 6.4.1 ESWL Procedures 237
    • 6.4.2 Stone Management Holmium Laser Procedures 238
    • 6.4.3 PCNL Procedures 239
    • 6.4.4 Ureteral Stent Placement Procedures 240
  • 6.5 NEPHROSTOMY PROCEDURES 241
  • 6.6 URINARY INCONTINENCE PROCEDURES 244
    • 6.6.1 Male Urinary Incontinence Procedures 248
    • 6.6.2 Female Urinary Incontinence Procedures 249
  • 6.7 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 250
    • 6.7.1 Inflatable Erectile Dysfunction Device Implant Procedures 254
    • 6.7.2 Malleable Erectile Dysfunction Device Implant Procedures 255

BPH TREATMENT DEVICE MARKET 256

  • 7.1 INTRODUCTION 256
    • 7.1.1 TURP 256
    • 7.1.2 Laser BPH 257
    • 7.1.3 Urolift 258
    • 7.1.4 Rezum® 258
  • 7.2 MARKET OVERVIEW 259
  • 7.3 MARKET ANALYSIS AND FORECAST 264
    • 7.3.1 Total TURP Device Market 264
      • 7.3.1.1 TURP Monopolar Electrode Market 274
      • 7.3.1.2 TURP Bipolar Electrode Market 281
    • 7.3.2 Total Laser BPH Device Market 289

291

      • 7.3.2.1 Laser BPH Capital Equipment Market 292
      • 7.3.2.2 Laser BPH Fiber Market 300
    • 7.3.3 UroLift Market 308
    • 7.3.4 Rezum Market 311
  • 7.4 DRIVERS AND LIMITERS 314
    • 7.4.1 Market Drivers 314
    • 7.4.2 Market Limiters 315
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 317

BRACHYTHERAPY MARKET 322

  • 8.1 INTRODUCTION 322
  • 8.2 MARKET ANALYSIS AND FORECAST 324
  • 8.3 DRIVERS AND LIMITERS 331
    • 8.3.1 Market Drivers 331
    • 8.3.2 Market Limiters 331
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS 333

URINARY CATHETER MARKET 336

  • 9.1 INTRODUCTION 336
  • 9.2 MARKET OVERVIEW 338
  • 9.3 MARKET ANALYSIS AND FORECAST 343
    • 9.3.1 Total Urinary Catheter Market 343
    • 9.3.2 Intermittent Urinary Catheter Market 351
    • 9.3.3 Foley Catheter Market 359
    • 9.3.4 Male External Catheter Market 366
  • 9.4 DRIVERS AND LIMITERS 374
    • 9.4.1 Market Drivers 374
    • 9.4.2 Market Limiters 374
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 376

NEPHROSTOMY DEVICE MARKET 381

  • 10.1 INTRODUCTION 381
  • 10.2 MARKET OVERVIEW 383
  • 10.3 MARKET ANALYSIS AND FORECAST 388
    • 10.3.1 Balloon Dilator Market 388
    • 10.3.2 Nephrostomy Tube Market 396
    • 10.3.3 Percutaneous Nephrostomy Access Market 403
  • 10.4 DRIVERS AND LIMITERS 411
    • 10.4.1 Market Drivers 411
    • 10.4.2 Market Limiters 411
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS 413

URINARY INCONTINENCE DEVICE MARKET 416

  • 11.1 INTRODUCTION 416
  • 11.2 MARKET OVERVIEW 418
  • 11.3 MARKET ANALYSIS AND FORECAST 423
    • 11.3.1 Urethral Bulking Agent Market 423
    • 11.3.2 Total Incontinence Sling Market 426
      • 11.3.2.1 Total Female Incontinence Sling Market 436
      • 11.3.2.1.1 Transvaginal Tape Female Incontinence Sling Market 446
      • 11.3.2.1.2 Transobturator Tape Female Incontinence Sling Market 453
      • 11.3.2.1.3 Single-Incision Female Incontinence Sling Market 460
      • 11.3.2.2 Male Incontinence Sling Market 467
  • 11.4 DRIVERS AND LIMITERS 474
    • 11.4.1 Market Drivers 474
    • 11.4.2 Market Limiters 474
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS 476

STONE MANAGEMENT DEVICE MARKET 480

  • 12.1 INTRODUCTION 480
  • 12.2 MARKET OVERVIEW 482
  • 12.3 MARKET ANALYSIS AND FORECAST 488
    • 12.3.1 Extracorporeal Shock Wave Lithotripsy Device Market 488
    • 12.3.2 Holmium Laser Fiber Market 491
    • 12.3.3 Total Stone Fragment Retrieval Device Market 498
      • 12.3.3.1 Nitinol Basket Market 509
      • 12.3.3.2 Nitinol Grasper Market 516
      • 12.3.3.3 Stainless Steel Basket Market 523
      • 12.3.3.4 Stainless Steel Grasper Market 530
    • 12.3.4 Ureteral Stent Market 537
  • 12.4 DRIVERS AND LIMITERS 544
    • 12.4.1 Market Drivers 544
    • 12.4.2 Market Limiters 545
  • 12.5 COMPETITIVE MARKET SHARE ANALYSIS 547

UROLOGICAL ENDOSCOPE MARKET 553

  • 13.1 INTRODUCTION 553
  • 13.2 MARKET OVERVIEW 555
  • 13.3 MARKET ANALYSIS AND FORECAST 561
    • 13.3.1 Total Urological Endoscope Market 561
    • 13.3.2 Total Cystoscope Market 563
      • 13.3.2.1 Rigid Cystoscope Market 568
      • 13.3.2.2 Total Flexible Cystoscope Market 570
      • 13.3.2.2.1 Flexible Fiber Optic Cystoscope Market 575
      • 13.3.2.2.2 Flexible Video Cystoscope Market 578
    • 13.3.3 Total Ureteroscope Market 581
      • 13.3.3.1 Semi-Rigid Ureteroscope Market 586
      • 13.3.3.2 Total Flexible Ureteroscope Market 588
      • 13.3.3.2.1 Flexible Fiber Optic Ureteroscope Market 593
      • 13.3.3.2.2 Flexible Video Ureteroscope Market 595
    • 13.3.4 Rigid Resectoscope Market 597
    • 13.3.5 Rigid Nephroscope Market 599
  • 13.4 DRIVERS AND LIMITERS 601
    • 13.4.1 Market Drivers 601
    • 13.4.2 Market Limiters 602
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS 603

ERECTILE DYSFUNCTION DEVICE MARKET 606

  • 14.1 INTRODUCTION 606
  • 14.2 MARKET OVERVIEW 608
  • 14.3 MARKET ANALYSIS AND FORECAST 613
    • 14.3.1 Total Erectile Dysfunction Device Market 613
    • 14.3.2 Inflatable Erectile Dysfunction Device Market 620
    • 14.3.3 Malleable Erectile Dysfunction Device Market 627
  • 14.4 DRIVERS AND LIMITERS 634
    • 14.4.1 Market Drivers 634
    • 14.4.2 Market Limiters 635
  • 14.5 COMPETITIVE MARKET SHARE ANALYSIS 636

Abbreviations 639

LIST OF CHARTS

  • Chart 1 1: Urological Device Market by Segment, Europe, 2015 - 2025 2
  • Chart 1 2: Urological Device Market Overview, Europe, 2018 & 2025 2
  • Chart 4 1: Urological Device Market by Segment, Europe, 2015 - 2025 153
  • Chart 4 2: Urological Device Market Breakdown, Europe, 2018 154
  • Chart 4 3: Urological Device Market Breakdown, Europe, 2025 155
  • Chart 4 4: Growth Rates by Segment, Urological Device Market, Europe, 2015 - 2025 158
  • Chart 4 5: Leading Competitors, Urological Device Market, Europe, 2018 168
  • Chart 5 1: Country Profile, Germany, 2018 201
  • Chart 5 2: Country Profile, France, 2018 202
  • Chart 5 3: Country Profile, United Kingdom, 2018 203
  • Chart 5 4: Country Profile, Italy, 2018 204
  • Chart 5 5: Country Profile, Spain, 2018 205
  • Chart 5 6: Country Profile, Benelux, 2018 206
  • Chart 5 7: Country Profile, Scandinavia, 2018 207
  • Chart 5 8: Country Profile, Austria, 2018 208
  • Chart 5 9: Country Profile, Switzerland, 2018 209
  • Chart 5 10: Country Profile, Portugal, 2018 210
  • Chart 6 1: Urological Procedures by Type, Europe, 2015 - 2025 213
  • Chart 6 2: Prostate Cancer Treatment Procedures by Type, Europe, 2015 - 2025 217
  • Chart 6 3: Interventional BPH Procedures by Type, Europe, 2015 - 2025 229
  • Chart 6 4: Stone Management Procedures by Type, Europe, 2015 - 2025 235
  • Chart 6 5: Nephrostomy Procedures, Europe, 2015 - 2025 243
  • Chart 6 6: Urinary Incontinence Procedures by Type, Europe, 2015 - 2025 246
  • Chart 6 7: Erectile Dysfunction Management Procedures by Type, Europe, 2013 - 2025 252
  • Chart 7 1: BPH Treatment Market by Segment, Europe, 2015 - 2025 261
  • Chart 7 2: BPH Treatment Market Breakdown, Europe, 2018 262
  • Chart 7 3: BPH Treatment Market Breakdown, Europe, 2025 263
  • Chart 7 4: TURP Device Market by Segment, Europe, 2015 - 2025 266
  • Chart 7 5: Total TURP Device Market, Europe, 2015 - 2025 268
  • Chart 7 6: TURP Monopolar Electrode Market, Europe, 2015 - 2025 275
  • Chart 7 7: TURP Bipolar Electrode Market, Europe, 2015 - 2025 283
  • Chart 7 8: Laser BPH Market by Segment, Europe, 2015 - 2025 291
  • Chart 7 8: Laser BPH Capital Equipment Market, Europe, 2015 - 2025 294
  • Chart 7 9: Laser BPH Fiber Market, Europe, 2015 - 2025 302
  • Chart 7 10: UroLift Market, Europe, 2015 - 2025 310
  • Chart 7 11: Rezum Market, Europe, 2015 - 2025 313
  • Chart 7 12: Leading Competitors, BPH Treatment Market, Europe, 2018 321
  • Chart 8 1: Brachytherapy Market, Europe, 2015 - 2025 325
  • Chart 8 2: Leading Competitors, Brachytherapy Market, Europe, 2018 335
  • Chart 9 1: Urinary Catheter Market by Segment, Europe, 2015 - 2025 340
  • Chart 9 2: Urinary Catheter Market Breakdown, Europe, 2018 341
  • Chart 9 3: Urinary Catheter Market Breakdown, Europe, 2025 342
  • Chart 9 4: Total Urinary Catheter Market, Europe, 2015 - 2025 345
  • Chart 9 5: Intermittent Urinary Catheter Market, Europe, 2015 - 2025 353
  • Chart 9 6: Foley Urinary Catheter Market, Europe, 2015 - 2025 360
  • Chart 9 7: Male External Catheter Market, Europe, 2015 - 2025 368
  • Chart 9 8: Leading Competitors, Urinary Catheter Market, Europe, 2018 380
  • Chart 10 1: Nephrostomy Device Market by Segment, Europe, 2015 - 2025 385
  • Chart 10 2: Nephrostomy Device Market Breakdown, Europe, 2018 386
  • Chart 10 3: Nephrostomy Device Market Breakdown, Europe, 2025 387
  • Chart 10 4: Balloon Dilator Market, Europe, 2015 - 2025 390
  • Chart 10 5: Nephrostomy Tube Market, Europe, 2015 - 2025 397
  • Chart 10 6: Percutaneous Nephrostomy Access Market, Europe, 2015 - 2025 405
  • Chart 10 7: Leading Competitors, Nephrostomy Market, Europe, 2018 415
  • Chart 11 1: Urinary Incontinence Device Market by Segment, Europe, 2015 - 2025 420
  • Chart 11 2: Urinary Incontinence Device Market Breakdown, Europe, 2018 421
  • Chart 11 3: Urinary Incontinence Device Market Breakdown, Europe, 2025 422
  • Chart 11 4: Urethral Bulking Agent Market, Europe, 2015 - 2025 425
  • Chart 11 5: Incontinence Sling Market by Segment, Europe, 2015 - 2025 428
  • Chart 11 6: Total Incontinence Sling Market, Europe, 2015 - 2025 430
  • Chart 11 7: Female Incontinence Sling Market by Segment, Europe, 2015 - 2025 438
  • Chart 11 8: Total Female Incontinence Sling Market, Europe, 2015 - 2025 440
  • Chart 11 9: Transvaginal Tape Female Incontinence Sling Market, Europe, 2015 - 2025 447
  • Chart 11 10: Transobturator Tape Female Incontinence Sling Market, Europe, 2015 - 2025 454
  • Chart 11 11: Single-Incision Female Incontinence Sling Market, Europe, 2015 - 2025 461
  • Chart 11 12: Male Incontinence Sling Market, Europe, 2015 - 2025 468
  • Chart 11 13: Leading Competitors, Urinary Incontinence Sling Market, Europe, 2018 479
  • Chart 12 1: Stone Management Device Market by Segment, Europe, 2015 - 2025 485
  • Chart 12 2: Stone Management Device Market Breakdown, Europe, 2018 486
  • Chart 12 3: Stone Management Device Market Breakdown, Europe, 2025 487
  • Chart 12 4: Extracorporeal Shock Wave Lithotripsy Device Market, Europe, 2015 - 2025 490
  • Chart 12 5: Holmium Laser Fiber Device Market, Europe, 2015 - 2025 492
  • Chart 12 6: Stone Fragment Retrieval Device Market by Segment, Europe, 2015 - 2025 501
  • Chart 12 7: Total Stone Fragment Retrieval Device Market, Europe, 2015 - 2025 503
  • Chart 12 8: Nitinol Basket Market, Europe, 2015 - 2025 510
  • Chart 12 9: Nitinol Grasper Market, Europe, 2015 - 2025 517
  • Chart 12 10: Stainless Steel Basket Market, Europe, 2015 - 2025 524
  • Chart 12 11: Stainless Steel Grasper Market, Europe, 2015 - 2025 531
  • Chart 12 12: Ureteral Stent Market, Europe, 2015 - 2025 538
  • Chart 12 13: Leading Competitors, Stone Management Device Market, Europe, 2018 552
  • Chart 13 1: Urological Endoscope Market by Segment, Europe, 2015 - 2025 558
  • Chart 13 2: Urological Endoscope Market Breakdown, Europe, 2018 559
  • Chart 13 3: Urological Endoscope Market Breakdown, Europe, 2025 560
  • Chart 13 4: Total Urological Endoscope Market, Europe, 2015 - 2025 562
  • Chart 13 5: Cystoscope Market by Segment, Europe, 2015 - 2025 565
  • Chart 13 6: Total Cystoscope Market, Europe, 2015 - 2025 567
  • Chart 13 7: Rigid Cystoscope Market, Europe, 2015 - 2025 569
  • Chart 13 8: Flexible Cystoscope Market by Segment, Europe, 2015 - 2025 572
  • Chart 13 9: Total Flexible Cystoscope Market, Europe, 2015 - 2025 574
  • Chart 13 10: Flexible Fiber Optic Cystoscope Market, Europe, 2015 - 2025 577
  • Chart 13 11: Flexible Video Cystoscope Market, Europe, 2015 - 2025 580
  • Chart 13 12: Ureteroscope Market by Segment, Europe, 2015 - 2025 583
  • Chart 13 13: Total Ureteroscope Market, Europe, 2015 - 2025 585
  • Chart 13 14: Semi-Rigid Ureteroscope Market, Europe, 2015 - 2025 587
  • Chart 13 15: Flexible Ureteroscope Market by Segment, Europe, 2015 - 2025 590
  • Chart 13 16: Total Flexible Ureteroscope Market, Europe, 2015 - 2025 592
  • Chart 13 17: Flexible Fiber Optic Ureteroscope Market, Europe, 2015 - 2025 594
  • Chart 13 18: Flexible Video Ureteroscope Market, Europe, 2015 - 2025 596
  • Chart 13 19: Rigid Resectoscope Market, Europe, 2015 - 2025 598
  • Chart 13 20: Rigid Nephroscope Market, Europe, 2015 - 2025 600
  • Chart 13 21: Leading Competitors, Urological Endoscope Market, Europe, 2018 605
  • Chart 14 1: Erectile Dysfunction Device Market by Segment, Europe, 2015 - 2025 610
  • Chart 14 2: Erectile Dysfunction Device Market Breakdown, Europe, 2018 611
  • Chart 14 3: Erectile Dysfunction Device Market Breakdown, Europe, 2025 612
  • Chart 14 4: Total Erectile Dysfunction Device Market, Europe, 2015 - 2025 614
  • Chart 14 5: Inflatable Erectile Dysfunction Device Market, Europe, 2015 - 2025 621
  • Chart 14 6: Malleable Erectile Dysfunction Device Market, Europe, 2015 - 2025 628
  • Chart 14 7: Leading Competitors, Erectile Dysfunction Device Market, Europe, 2018 638

LIST OF FIGURES

  • Figure 1 1: Urological Device Market Share Ranking by Segment, Europe, 2018 3
  • Figure 1 2: Urological Device Market Share Ranking by Segment, Europe, 2018 3
  • Figure 1 3: Companies Researched in this Report (1 of 2) 4
  • Figure 1 4: Companies Researched in this Report (2 of 2) 5
  • Figure 1 5: Factors Impacting the Urological Device Market by Segment, Europe, (Part 1 of 2) 6
  • Figure 1 6: Factors Impacting the Urological Device Market by Segment, Europe, (Part 2 of 2) 7
  • Figure 1 7: Recent Events in the Urological Device Market, Europe, 2015 - 2018 8
  • Figure 1 8: Urological Device Procedures Covered, Europe 9
  • Figure 1 9: Urological Device Markets Covered, Europe, (Part 1 of 2) 10
  • Figure 1 10: Urological Device Markets Covered, Europe, (Part 2 of 2) 11
  • Figure 1 11: Key Report Updates 12
  • Figure 1 12: Version History 12
  • Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 59
  • Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 60
  • Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 61
  • Figure 3 4: Stone Management Devices by Company (1 of 3) 65
  • Figure 3 5: Stone Management Devices by Company (2 of 3) 66
  • Figure 3 6: Stone Management Devices by Company (3 of 3) 67
  • Figure 3 7: BPH Treatments by Company 76
  • Figure 3 8: Urological Endoscopes by Company (1 of 3) 80
  • Figure 3 9: Urological Endoscopes by Company (2 of 3) 81
  • Figure 3 10: Urological Endoscopes by Company (3 of 3) 82
  • Figure 3 11: Prostate Cancer Treatments by Company 86
  • Figure 3 12: Urodynamic Equipment and Consumables by Company 90
  • Figure 3 13: Nephrostomy Devices by Company (1 of 3) 93
  • Figure 3 14: Nephrostomy Devices by Company (2 of 3) 94
  • Figure 3 15: Nephrostomy Devices by Company (3 of 3) 95
  • Figure 3 16: Erectile Dysfunction Devices by Company 98
  • Figure 3 17: Class 2 Device Recall Auriga Laser System 99
  • Figure 3 18: Class 2 Device Recall Fiber Strippers and Cleavers 100
  • Figure 3 19: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 101
  • Figure 3 20: Class 2 Device Recall Malecot Catheter Set 101
  • Figure 3 21: Class 2 Device Recall Encore(TM) 26 Inflation Device 101
  • Figure 3 22: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 102
  • Figure 3 23: Class 2 Device Recall Intermittent Catheters 102
  • Figure 3 24: Class 2 Device Recall leg bag 102
  • Figure 3 25: Class 2 Device Recall SURESTEP 103
  • Figure 3 26: Class 2 Device Recall PureWick External Catheter 103
  • Figure 3 27: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 103
  • Figure 3 28: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 104
  • Figure 3 29: Class 2 Device Recall Magic3 104
  • Figure 3 30: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 104
  • Figure 3 31: Class 3 Device Recall SureStep Tray, with AddaFoley 105
  • Figure 3 32: Class 2 Device Recall BARDEX 105
  • Figure 3 33: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 105
  • Figure 3 34: Class 3 Device Recall Antibacterial Hydro Personal Catheter 105
  • Figure 3 35: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 106
  • Figure 3 36: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 106
  • Figure 3 37: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 106
  • Figure 3 38: Class 2 Device Recall Bard Dimension Stone Basket 107
  • Figure 3 39: Class 2 Device Recall CMax 107
  • Figure 3 40: Class 2 Device Recall Bard BrachySource Seed Implants 107
  • Figure 3 41: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 108
  • Figure 3 42: Class 2 Device Recall Bard 108
  • Figure 3 43: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 109
  • Figure 3 44: Class 2 Device Recall SelfCath Pediatric Catheter 110
  • Figure 3 45: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 110
  • Figure 3 46: Class 2 Device Recall Genesis Malleable Penile Prosthesis 110
  • Figure 3 47: Class 2 Device Recall StoneBreaker 111
  • Figure 3 48: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 111
  • Figure 3 49: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 112
  • Figure 3 50: Class 2 Device Recall Cook Bush 112
  • Figure 3 51: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 112
  • Figure 3 52: Class 2 Device Recall Ascend AQ 113
  • Figure 3 53: Class 2 Device Recall Oncentra Brachy 4.5 114
  • Figure 3 54: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 114
  • Figure 3 55: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 114
  • Figure 3 56: Class 2 Device Recall Oncentra Brachy treatment planning system 114
  • Figure 3 57: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 115
  • Figure 3 58: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 115
  • Figure 3 59: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 116
  • Figure 3 60: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 116
  • Figure 3 61: Class 2 Device Recall Olympus High Freqency Resection Electrodes 116
  • Figure 3 62: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 117
  • Figure 3 63: Class 2 Device Recall HF Cable WA00014A 117
  • Figure 3 64: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 118
  • Figure 3 65: Mid-Urethral Sling Tensioning Trial (MUST) 118
  • Figure 3 66: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 119
  • Figure 3 67: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 119
  • Figure 3 68: LithoVue Single Use Disposable Ureteroscope 120
  • Figure 3 69: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 120
  • Figure 3 70: Indwelling Stent Discoloration Project 121
  • Figure 3 71: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 121
  • Figure 3 72: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 122
  • Figure 3 73: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 123
  • Figure 3 74: Foley Catheter vs a Self-contained Valved Urinary Catheter 123
  • Figure 3 75: Bladder Morphology Using 2 Different Catheter Designs 124
  • Figure 3 76: Outpatient Labor Induction With the Transcervical Foley Balloon 124
  • Figure 3 77: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 125
  • Figure 3 78: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 125
  • Figure 3 79: Product Evaluation of a Newly Developed Intermittent Catheter. 126
  • Figure 3 80: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 126
  • Figure 3 81: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 126
  • Figure 3 82: Virtue® European Study 127
  • Figure 3 83: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 127
  • Figure 3 84: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 127
  • Figure 3 85: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 128
  • Figure 3 86: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 128
  • Figure 3 87: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 128
  • Figure 3 88: Ureteral Stent Study 129
  • Figure 3 89: Impact Ureteral Sheath Design During Ureteroscopy 129
  • Figure 3 90: Optimization of Ureterolysis During Hysterectomy 130
  • Figure 3 91: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 130
  • Figure 3 92: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 131
  • Figure 3 93: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 131
  • Figure 3 94: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 132
  • Figure 3 95: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 132
  • Figure 3 96: Combined Treatment for Mixed Incontinence (ESTEEM) 133
  • Figure 3 97: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 133
  • Figure 3 98: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 134
  • Figure 3 99: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 135
  • Figure 3 100: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 135
  • Figure 3 101: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 136
  • Figure 3 102: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 136
  • Figure 3 103: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 136
  • Figure 3 104: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 137
  • Figure 3 105: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 137
  • Figure 3 106: Comparison of Different Energy Sources During TUR-P 137
  • Figure 3 107: Effects of Flexible Ureteroscopy on Renal Blood Flow 138
  • Figure 3 108: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 138
  • Figure 3 109: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 138
  • Figure 3 110: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 139
  • Figure 3 111: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 139
  • Figure 3 112: T-DOC® 5 Fr Pediatric Clinical Investigation 140
  • Figure 3 113: Air vs Water Catheters (AvW (Bonn)) 140
  • Figure 3 114: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 140
  • Figure 3 115: Portable Pves Study 141
  • Figure 3 116: Ambulatory Pessary Trial 141
  • Figure 3 117: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 142
  • Figure 3 118: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 142
  • Figure 3 119: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 143
  • Figure 3 120: Quality of Life in Kidney Stone Patients Undergoing Surgery 143
  • Figure 3 121: Prostate Vaporization Techniques in Canadian Hospital 144
  • Figure 3 122: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 144
  • Figure 3 123: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 145
  • Figure 3 124: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 145
  • Figure 3 125: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 145
  • Figure 3 126: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 146
  • Figure 4 1: Currency Exchange Rate, 2018 147
  • Figure 4 2: Urological Device Market by Segment, Europe, 2015 - 2025 (€M) (1 of 2) 149
  • Figure 4 3: Urological Device Market by Segment, Europe, 2015 - 2025 (€M) (2 of 2) 150
  • Figure 4 4: Urological Device Market by Segment, Europe, 2015 - 2025 (US$M) (1 of 2) 151
  • Figure 4 5: Urological Device Market by Segment, Europe, 2015 - 2025 (US$M) (2 of 2) 152
  • Figure 4 6: Urological Device Market Growth by Segment, Europe, 2015 - 2025 (1 of 2) 157
  • Figure 4 7: Urological Device Market Growth by Segment, Europe, 2015 - 2025 (2 of 2) 157
  • Figure 4 8: Drivers and Limiters, Urological Device Market, Europe, 2018 161
  • Figure 4 9: Leading Competitors, Urological Device Market, Europe, 2018 (1 of 2) 166
  • Figure 4 10: Leading Competitors, Urological Device Market, Europe, 2018 (2 of 2) 167
  • Figure 4 8: SWOT Analysis, Boston Scientific, 2018 (1 of 2) 185
  • Figure 4 9: SWOT Analysis, Boston Scientific, 2018 (2 of 2) 186
  • Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (1 of 2) 187
  • Figure 4 11: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (2 of 2) 188
  • Figure 4 12: SWOT Analysis, Coloplast, 2018 189
  • Figure 4 13: SWOT Analysis, Cook Medical, 2018 (1 of 2) 190
  • Figure 4 14: SWOT Analysis, Cook Medical, 2018 (2 of 2) 191
  • Figure 4 15: SWOT Analysis, Elekta, 2018 192
  • Figure 4 16: SWOT Analysis, Ethicon, 2018 193
  • Figure 4 17: SWOT Analysis, Karl Storz, 2018 194
  • Figure 4 18: SWOT Analysis, Laborie, 2018 195
  • Figure 4 19: SWOT Analysis, Medline, 2018 (1 of 2) 196
  • Figure 4 20: SWOT Analysis, Medline, 2018 (2 of 2) 197
  • Figure 4 21: SWOT Analysis, Olympus, 2018 (1 of 2) 198
  • Figure 4 22: SWOT Analysis, Olympus, 2018 (2 of 2) 199
  • Figure 6 1: Urological Procedures by Type, Europe, 2015 - 2025 212
  • Figure 6 2: Prostate Cancer Procedures by Type, Europe, 2015 - 2025 (1 of 2) 216
  • Figure 6 2: Prostate Cancer Procedures by Type, Europe, 2015 - 2025 (2 of 2) 216
  • Figure 6 3: Total Prostate Cancer Procedures by Country, Europe, 2015 - 2025 218
  • Figure 6 4: Open and Laparoscopic Prostatectomy Procedures by Country, Europe, 2015 - 2025 219
  • Figure 6 5: Robotic Prostatectomy Procedures by Country, Europe, 2015 - 2025 220
  • Figure 6 6: Watchful Waiting Procedures by Country, Europe, 2015 - 2025 221
  • Figure 6 7: HIFU Procedures by Country, Europe, 2015 - 2025 222
  • Figure 6 8: Brachytherapy Procedures by Country, Europe, 2015 - 2025 223
  • Figure 6 9: High Dose Radiation Procedures by Country, Europe, 2015 - 2025 224
  • Figure 6 10: External Radiation Therapy (Primary) Procedures by Country, Europe, 2015 - 2025 225
  • Figure 6 11: External Radiation Therapy (Secondary) Procedures by Country, Europe, 2015 - 2025 226
  • Figure 6 12: Interventional BPH Procedures by Type, Europe, 2015 - 2025 228
  • Figure 6 13: Total Interventional BPH Procedures by Country, Europe, 2015 - 2025 230
  • Figure 6 14: TURP Procedures by Country, Europe, 2015 - 2025 231
  • Figure 6 15: Laser BPH Procedures by Country, Europe, 2015 - 2025 232
  • Figure 6 16: Stone Management Procedures by Type, Europe, 2015 - 2025 234
  • Figure 6 17: Total Stone Management Procedures by Country, Europe, 2015 - 2025 236
  • Figure 6 18: ESWL Procedures by Country, Europe, 2015 - 2025 237
  • Figure 6 19: Stone Management Holmium Laser Procedures by Country, Europe, 2015 - 2025 238
  • Figure 6 20: PCNL Procedures by Country, Europe, 2015 - 2025 239
  • Figure 6 21: Ureteral Stent Placement Procedures by Country, Europe, 2015 - 2025 240
  • Figure 6 22: Nephrostomy Procedures by Country, Europe, 2015 - 2025 242
  • Figure 6 23: Urinary Incontinence Procedures by Type, Europe, 2015 - 2025 245
  • Figure 6 24: Total Urinary Incontinence Procedures by Country, Europe, 2015 - 2025 247
  • Figure 6 25: Male Urinary Incontinence Procedures by Country, Europe, 2015 - 2025 248
  • Figure 6 26: Female Urinary Incontinence Procedures by Country, Europe, 2015 - 2025 249
  • Figure 6 27: Erectile Dysfunction Management Procedures by Type, Europe, 2015 - 2025 251
  • Figure 6 28: Total Erectile Dysfunction Management Procedures by Country, Europe, 2015 - 2025 253
  • Figure 6 29: Inflatable Erectile Dysfunction Device Implant Procedures by Country, Europe, 2015 - 2025 254
  • Figure 6 30: Malleable Erectile Dysfunction Device Implant Procedures by Country, Europe, 2015 - 2025 255
  • Figure 7 1: BPH Treatment Market by Segment, Europe, 2015 - 2025 (€M) 259
  • Figure 7 2: BPH Treatment Market by Segment, Europe, 2015 - 2025 (US$M) 260
  • Figure 7 3: TURP Device Market by Segment, Europe, 2015 - 2025 (€M) 265
  • Figure 7 4: TURP Device Market by Segment, Europe, 2015 - 2025 (US$M) 265
  • Figure 7 5: Total TURP Device Market, Europe, 2015 - 2025 267
  • Figure 7 6: Units Sold by Country, Total TURP Device Market, Europe, 2015 - 2025 269
  • Figure 7 7: Average Selling Price by Country, Total TURP Device Market, Europe, 2015 - 2025 (€) 270
  • Figure 7 8: Average Selling Price by Country, Total TURP Device Market, Europe, 2015 - 2025 (US$) 271
  • Figure 7 9: Market Value by Country, Total TURP Device Market, Europe, 2015 - 2025 (€M) 272
  • Figure 7 10: Market Value by Country, Total TURP Device Market, Europe, 2015 - 2025 (US$M) 273
  • Figure 7 11: TURP Monopolar Electrode Market, Europe, 2015 - 2025 274
  • Figure 7 12: Units Sold by Country, TURP Monopolar Electrode Market, Europe, 2015 - 2025 276
  • Figure 7 13: Average Selling Price by Country, TURP Monopolar Electrode Market, Europe, 2015 - 2025 (€) 277
  • Figure 7 14: Average Selling Price by Country, TURP Monopolar Electrode Market, Europe, 2015 - 2025 (US$) 278
  • Figure 7 15: Market Value by Country, TURP Monopolar Electrode Market, Europe, 2015 - 2025 (€M) 279
  • Figure 7 16: Market Value by Country, TURP Monopolar Electrode Market, Europe, 2015 - 2025 (US$M) 280
  • Figure 7 17: TURP Bipolar Electrode Market, Europe, 2015 - 2025 282
  • Figure 7 18: Units Sold by Country, TURP Bipolar Electrode Market, Europe, 2015 - 2025 284
  • Figure 7 19: Average Selling Price by Country, TURP Bipolar Electrode Market, Europe, 2015 - 2025 (€) 285
  • Figure 7 20: Average Selling Price by Country, TURP Bipolar Electrode Market, Europe, 2015 - 2025 (US$) 286
  • Figure 7 21: Market Value by Country, TURP Bipolar Electrode Market, Europe, 2015 - 2025 (€M) 287
  • Figure 7 22: Market Value by Country, TURP Bipolar Electrode Market, Europe, 2015 - 2025 (US$M) 288
  • Figure 7 23: Laser BPH Market by Segment, Europe, 2015 - 2025 (€M) 290
  • Figure 7 24: Laser BPH Market by Segment, Europe, 2015 - 2025 (US$M) 290
  • Figure 7 25: Laser BPH Capital Equipment Market, Europe, 2015 - 2025 293
  • Figure 7 26: Units Sold by Country, Laser BPH Capital Equipment Market, Europe, 2015 - 2025 295
  • Figure 7 27: Average Selling Price by Country, Laser BPH Capital Equipment Market, Europe, 2015 - 2025 (€) 296
  • Figure 7 28: Average Selling Price by Country, Laser BPH Capital Equipment Market, Europe, 2015 - 2025 (US$) 297
  • Figure 7 29: Market Value by Country, Laser BPH Capital Equipment Market, Europe, 2015 - 2025 (€M) 298
  • Figure 7 30: Market Value by Country, Laser BPH Capital Equipment Market, Europe, 2015 - 2025 (US$M) 299
  • Figure 7 31: Laser BPH Fiber Market, Europe, 2015 - 2025 301
  • Figure 7 32: Units Sold by Country, Laser BPH Fiber Market, Europe, 2015 - 2025 303
  • Figure 7 33: Average Selling Price by Country, Laser BPH Fiber Market, Europe, 2015 - 2025 (€) 304
  • Figure 7 34: Average Selling Price by Country, Laser BPH Fiber Market, Europe, 2015 - 2025 (US$) 305
  • Figure 7 35: Market Value by Country, Laser BPH Fiber Market, Europe, 2015 - 2025 (€M) 306
  • Figure 7 36: Market Value by Country, Laser BPH Fiber Market, Europe, 2015 - 2025 (US$M) 307
  • Figure 7 37: UroLift Market, Europe, 2015 - 2025 309
  • Figure 7 38: Rezum Market, Europe, 2015 - 2025 312
  • Figure 7 39: Drivers and Limiters, BPH Treatment Market, Europe, 2018 316
  • Figure 7 40: Leading Competitors, BPH Treatment Market, Europe, 2018 320
  • Figure 8 1: Brachytherapy Market, Europe, 2015 - 2025 324
  • Figure 8 2: Units Sold by Country, Brachytherapy Market, Europe, 2015 - 2025 326
  • Figure 8 3: Average Selling Price by Country, Brachytherapy Market, Europe, 2015 - 2025 (€) 327
  • Figure 8 4: Average Selling Price by Country, Brachytherapy Market, Europe, 2015 - 2025 (US$) 328